The Blood Type Diet: Science, Controversy, and What the Research Shows

I have an unusual relationship with the Blood Type Diet. As a long-time contributor to Dr. D'Adamo's Opus 23 database — a system I've helped build to over 16,000 entries — I have seen both its genuine insights and its limitations up close. The honest answer to "does the Blood Type Diet work?" is: it's complicated, and the full truth is more interesting than either its advocates or critics typically acknowledge.

The Core Theory: Lectins and Blood Type Antigens

The Blood Type Diet, first published in D'Adamo's 1996 book "Eat Right 4 Your Type," proposes that your ABO blood type determines how your body responds to dietary lectins — proteins found in many foods, particularly grains, legumes, and certain vegetables. Lectins bind to specific carbohydrate structures on cell surfaces, and those structures differ by blood type. The theory holds that lectins incompatible with your blood type antigens cause agglutination — essentially clumping cells together — which triggers inflammation and digestive dysfunction.

The core biochemical mechanism — that ABO antigens exist and that lectins interact with carbohydrate structures — is not controversial. What is debated is the clinical significance of these interactions in normal dietary quantities and the degree to which blood type alone determines health outcomes.

What the Research Actually Shows

A widely cited 2013 review in the American Journal of Clinical Nutrition examined 1,415 studies and found no evidence that blood type-specific diets produce differential health benefits based on blood type. However, this review was critiqued for not examining blood type-specific outcomes specifically. A 2014 study from the University of Toronto found that specific diets recommended for Type A and Type AB produced general health benefits — but these occurred regardless of blood type.

What this suggests is not that the diets are ineffective, but that their benefits may arise from general dietary quality improvements rather than blood type specificity alone. This is a nuanced finding that neither definitively validates nor invalidates the framework.

Secretor Status: The Missing Variable

One area where the glycomics field has genuinely advanced is secretor status. The FUT2 gene determines whether you secrete your blood type antigens into bodily fluids — and approximately 20% of the population are non-secretors. Non-secretors have distinctly different gut microbiome compositions and different immune responses to dietary lectins than secretors. This variable, which D'Adamo has long incorporated into his SWAMI (Personalized Dietary Software) program, adds meaningful precision to blood type-based nutritional recommendations.

At Genetic Wellbeing, glycomics — including ABO, Rh, Lewis secretor, and Lewis non-secretor status — is integrated into our Complete Multi-Omics analysis. It is one meaningful layer in a comprehensive protocol, contextualized alongside full genetic analysis, microbiome composition, and individual health history. That is where the real power lies.